| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3842fe0947af85a544bf86e98481b103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fd8cc3444e7653c3c9498370e5124c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1713462a06e186635ba771fc27e5c1ce |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2320-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-111
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-203
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-203 |
| filingDate |
2011-03-10^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-03-03^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a95be6b032dbe60b3670d658912eef6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d3b0cc7a1d0be5b9717febcb69feabc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b16e567bd997cf84e835d508647b21a |
| publicationDate |
2015-03-03^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8969544-B2 |
| titleOfInvention |
Combined use of PRAME inhibitors and HDAC inhibitors |
| abstract |
The invention relates to the cancer antigen PRAME (PReferentially expressed Antigen in MElanoma) and its use in a method of treatment of a tumour which comprises administering to a subject in need of treatment an effective amount of an inhibitor of PRAME, in combination with a second agent selected from the group of an inhibitor of HDAC (an HDACi) and a retinoid. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11338029-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111465405-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111465405-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4218798-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019118763-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2748903-C1 |
| priorityDate |
2004-01-28^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |